Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, PR China.
Vaccine. 2010 Mar 19;28(14):2636-41. doi: 10.1016/j.vaccine.2010.01.016. Epub 2010 Jan 20.
Streptococcus iniae is a Gram-positive bacterium and a severe aquaculture pathogen that can infect a wide range of farmed fish species. In the summer of 2006, an epidemic broke out in a fish farm in north China, and examination of moribund fish (Japanese flounder) identified the possible etiological agent of the outbreak as a strain named SF1, which exhibited apparent virulence in a Japanese flounder infection model and conforms to the description of S. iniae by 16S rRNA sequence analysis and API 20 Strep test. Biochemical and random amplified polymorphic DNA analyses indicated that SF1 is of the serotype I. A putative iron-binding protein, Sip11, was identified from SF1 using a previously established molecular trap that selects exported proteins. Recombinant Sip11 was purified from Escherichia coli and found to be protective against SF1 infection when used as an injection vaccine administered intraperitoneally into Japanese flounder. To improve the vaccine potential of Sip11, an E. coli strain was constructed, which expresses and secrets recombinant Sip11 covalently linked to a carrier protein in the form of a chimera. Vaccination of Japanese flounder with live Sip11-secreting E. coli afforded complete protection upon the fish following lethal SF1 challenge. These results indicate that Sip11, especially when delivered by a live bacterial carrier, is an effective vaccine candidate against SF1 infection.
无乳链球菌是一种革兰氏阳性菌,也是一种严重的水产养殖病原体,可以感染多种养殖鱼类。2006 年夏季,中国北方的一个养鱼场爆发了一场疫情,对濒死鱼(日本牙鲆)的检查确定了此次疫情的可能病原体是一个名为 SF1 的菌株,该菌株在日本牙鲆感染模型中表现出明显的毒力,并且通过 16S rRNA 序列分析和 API 20 链球菌测试符合无乳链球菌的描述。生化和随机扩增的多态性 DNA 分析表明 SF1 是血清型 I。使用先前建立的选择分泌蛋白的分子陷阱,从 SF1 中鉴定出一种假定的铁结合蛋白 Sip11。从大肠杆菌中纯化出重组 Sip11,当用作腹腔内注射的日本牙鲆注射疫苗时,对 SF1 感染具有保护作用。为了提高 Sip11 的疫苗潜力,构建了一种表达和分泌重组 Sip11 的大肠杆菌菌株,该 Sip11 以融合蛋白的形式与载体蛋白共价连接。用活的分泌 Sip11 的大肠杆菌对日本牙鲆进行免疫接种,在鱼受到致命 SF1 攻击后,可提供完全保护。这些结果表明 Sip11,特别是当通过活细菌载体传递时,是针对 SF1 感染的有效疫苗候选物。